Home > News > TGen is forming company with ASU
January 22nd, 2004
TGen is forming company with ASU
Abstract:
Arizona State University and the Translational Genomics Research Institute in Phoenix plan to bring new medical diagnostic technologies to market through a new company. At its monthly meeting Friday, the Arizona Board of Regents is expected to approve an agreement to allow ASU to license molecular diagnostics technology to the new company, Nanobiomics Inc. The genomics institute, known as TGen, also will license its technology to the company.
Source:
Arizona Daily Star
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||